17478-609 : Zioptan .0045 mg/.3ml Ophthalmic Solution/ Drops


NDC: 17478-609
Labeler: Akorn, Inc.
Product Type: Human Prescription Drug
Drug Name:  Zioptan
Dosage Form: Ophthalmic Solution/ Drops
Application #: NDA202514
Rev. Date: 


NDC Package Codes:

  • 17478-609-10: 1 POUCH IN 1 CARTON (17478‑609‑10) > 10 VIAL, SINGLE‑USE IN 1 POUCH (17478‑609‑01) > .3 ML IN 1 VIAL, SINGLE‑USE
  • 17478-609-30: 3 POUCH IN 1 CARTON (17478‑609‑30) > 10 VIAL, SINGLE‑USE IN 1 POUCH (17478‑609‑01) > .3 ML IN 1 VIAL, SINGLE‑USE
  • 17478-609-90: 9 POUCH IN 1 CARTON (17478‑609‑90) > 10 VIAL, SINGLE‑USE IN 1 POUCH (17478‑609‑01) > .3 ML IN 1 VIAL, SINGLE‑USE

Active Ingredients:

  • Tafluprost

Dosage Strength:

  • .0045 mg/.3mL

Pharmaceutical Classes:

  • Prostaglandin Analog [EPC]
  • Prostaglandin Receptor Agonists [MoA]
  • Increased Prostaglandin Activity [PE]
  • Prostaglandins [CS]

Related Products:

Based on records with the same trade name.
  • 0006-3931 Zioptan .0045 mg/.3ml Ophthalmic Solution by Merck Sharp & Dohme Corp.
  • 82584-609 Zioptan .015 mg/ml Ophthalmic Solution/ Drops by Thea Pharma Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 17478-609 QR Code

< Prev: 17478-608Next: 17478-620 >

Related Discussions:

tafluprost
pharmacokinetic and pharmacodynamic...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.